Newsroom | 72156 results

NEW YORK--(BUSINESS WIRE)--Researchers at Hospital for Special Surgery (HSS) have identified a specialized population of immune cells that play a central role in driving abnormal tissue growth in rheumatoid arthritis (RA), offering new insight into disease progression and potential treatment strategies. The study, published in Science Translational Medicine, reveals that a subset of immune cells known as SPP1ʰⁱ macrophages work in tandem with structural cells and protein scaffolds to promote ex...

NEW YORK--(BUSINESS WIRE)--Eckuity Capital, a North American healthcare growth equity firm, today announced the first close of Eckuity Capital Fund II and the fund’s inaugural investment, leading the Series C of Automata Technologies alongside Danaher, a global science and technology leader. Automata uses artificial intelligence to automate laboratory operations for life sciences and diagnostics organisations, work that has long been manual, slow, and hard to scale. Backing from Eckuity and Dan...

MONTREAL--(BUSINESS WIRE)--Nomic Bio Inc., today announced they will partner with the Health and Environmental Sciences Institute’s (HESI Global) Omics for Assessing Signatures for Integrated Safety (OASIS) Consortium to identify biomarker signatures for liver toxicity using large-scale protein profiling of human liver-derived cell models. The OASIS Consortium is designed to support more predictive, efficient, and human-relevant approaches to compound safety assessment, consistent with the grow...

LOS ANGELES--(BUSINESS WIRE)--Leveraging trusted automation from Leica Biosystems, HCR™ Gold IF helps researchers move from tissue to insight faster with flexible, higher-plex IF....

ST. LOUIS--(BUSINESS WIRE)--Agragene announces funding from the USDA New World Screwworm Grand Challenge and from the Foundation for Food & Agriculture Research. The grants were awarded through competitive processes by both USDA and FFAR with the former involving hundreds of submissions. Both grants are designed to facilitate additional research on the company’s novel insect sterility technology.Agragene uses precision-guided sterile insect technique (pgSIT) to deliver healthy, sterile male...

TAMPA, Fla.--(BUSINESS WIRE)--ReliaQuest today announced a $1.5 million investment to expand AI cybersecurity research and education at the University of South Florida’s College of Artificial Intelligence, Cybersecurity and Computing. The gift will establish the college’s first-ever endowed professorship and create a new study track within the ReliaQuest Labs program focused on artificial intelligence-supported software engineering. “Cybersecurity is the greatest technical challenge of our gene...

CAMBRIDGE, England--(BUSINESS WIRE)--Constructive Bio’s founder and Chief Scientific Officer, Professor Jason Chin, has been named the recipient of the 2026 Heinrich Wieland Prize, one of Europe’s most prestigious honours for fundamental research in the life sciences. The award places Professor Chin among past laureates, including five Nobel Prize winners, and recognises the genetic-code-expansion technology now being applied to next-generation therapeutics, including GLP-1s. The award, present...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Quantori's MLConfGen wins the Machine Learning Innovation Award at the 2026 AI Breakthrough Awards for advancing AI-assisted molecular design....

EATONTOWN, N.J.--(BUSINESS WIRE)--Clinilabs (“Clinilabs LLC”), a global full‑service CRO specializing in CNS drug and device development, announced a new partnership with Rutgers Health, School of Health Professions, Master of Science, Clinical Research Management program (MS CRM), reflecting the company’s ongoing commitment to advancing scientific education and strengthening the future clinical research workforce. As one of the nation’s leading public research institutions, Rutgers brings exce...

IRVINE, Calif.--(BUSINESS WIRE)--Immunis, a clinical-stage biotech company developing a first-in-class multi-active biologic, announced the launch of its new logo and brand identity. The rebrand reflects the company’s scientific focus on multi-pathway biology and its mission to improve muscle function, metabolic health, and overall healthspan. Immunis’ platform is built on the understanding that age-related and chronic diseases are driven by interconnected biological pathways. Unlike convention...